Evidence map›Paper›PMID 39577431›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Improving efficacy of in vivo therapy of sickle cell disease by hijacking natural biology of hematopoietic stem cells.

Jia Yao, Dmitry M Shayakhmetov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jia YaoLowance Center for Human Immunology, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Dmitry M ShayakhmetovLowance Center for Human Immunology, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA; Discovery and Developmental Therapeutics Program, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA. Electronic address: dmitryshay@emory.edu.

Funding

Mechanistic factors limiting utility of adenovirus vectors for treatment of neoplaR01CA267694 · NCI · EMORY UNIVERSITY · PI Dmitry Shayakhmetov · 2022 to 2026
$3.1M
Molecular mechanisms of adenovirus neutralizationR37AI107960 · NIAID · EMORY UNIVERSITY · PI PHOEBE L STEWART, Dmitry Shayakhmetov · 2026 to 2026
$806k
NCI NIH HHS R01 CA267694NIAID NIH HHS R37 AI107960
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39577431
PMCPMC11638860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.